Post-translational regulation could determine functional differences between SET alpha and beta isoforms in chronic lymphocytic leukaemia

Br J Haematol. 2019 Aug;186(4):638. doi: 10.1111/bjh.15935. Epub 2019 Apr 24.

Authors

Ion Cristóbal^{1

2}, Marta Sanz-Alvarez³, Melani Luque³, Federico Rojo³, Jesús García-Foncillas^{1

2}

Affiliations

¹ Cancer Unit for Research on Novel Therapeutic Targets, Oncohealth Institute, IIS-Fundación Jiménez Díaz-UAM, Madrid, Spain.
² Translational Oncology Division, Oncohealth Institute, IIS-Fundación Jiménez Díaz-UAM, Madrid, Spain.
³ Pathology Department, IIS-Fundación Jiménez Díaz-UAM, Madrid, Spain.

PMID: 31020656
DOI: 10.1111/bjh.15935

No abstract available

Keywords: SET; PP2A; post-translational regulation.

Publication types

Letter
Research Support, Non-U.S. Gov't
Comment

MeSH terms

Humans
Leukemia, Lymphocytic, Chronic, B-Cell*
Protein Isoforms
RNA Isoforms
RNA, Messenger

Substances

Protein Isoforms
RNA Isoforms
RNA, Messenger